{'52WeekChange': None,
 'SandP52WeekChange': None,
 'algorithm': None,
 'annualHoldingsTurnover': None,
 'annualReportExpenseRatio': None,
 'ask': 23.62,
 'askSize': 2200,
 'averageDailyVolume10Day': 7312,
 'averageVolume': 10376,
 'averageVolume10days': 7312,
 'beta': None,
 'beta3Year': 0.92,
 'bid': 23.43,
 'bidSize': 1200,
 'bookValue': None,
 'category': 'Health',
 'circulatingSupply': None,
 'companyOfficers': [],
 'currency': 'USD',
 'dayHigh': 24.41,
 'dayLow': 23.4643,
 'dividendRate': None,
 'dividendYield': None,
 'earningsQuarterlyGrowth': None,
 'enterpriseToEbitda': None,
 'enterpriseToRevenue': None,
 'enterpriseValue': None,
 'exDividendDate': None,
 'exchange': 'NGM',
 'exchangeTimezoneName': 'America/New_York',
 'exchangeTimezoneShortName': 'EDT',
 'expireDate': None,
 'fiftyDayAverage': 23.08483,
 'fiftyTwoWeekHigh': 24.889,
 'fiftyTwoWeekLow': 16.28,
 'fiveYearAverageReturn': None,
 'fiveYearAvgDividendYield': None,
 'forwardEps': None,
 'forwardPE': None,
 'fromCurrency': None,
 'fundFamily': 'First Trust',
 'fundInceptionDate': 1474329600,
 'gmtOffSetMilliseconds': '-14400000',
 'isEsgPopulated': False,
 'lastCapGain': None,
 'lastDividendValue': None,
 'lastFiscalYearEnd': None,
 'lastMarket': None,
 'lastSplitDate': None,
 'lastSplitFactor': None,
 'legalType': 'Exchange Traded Fund',
 'logo_url': '',
 'longBusinessSummary': 'The investment seeks investment results that '
                        'correspond generally to the price and yield (before '
                        'the fund&#39;s fees and expenses) of the Nasdaq US '
                        'Smart Pharmaceuticals Index.\n'
                        ' The fund will normally invest at least 90% of its '
                        'net assets (including investment borrowings) in the '
                        'common stocks and depository receipts that comprise '
                        'the index. The index is designed to provide exposure '
                        'to U.S. companies comprising the pharmaceutical '
                        'sector that have been selected based upon their '
                        'liquidity and weighted based upon their cumulative '
                        'score on three investing factors: volatility, value '
                        'and growth. It is non-diversified.',
 'longName': 'First Trust Nasdaq Pharmaceuticals ETF',
 'market': 'us_market',
 'marketCap': None,
 'maxAge': 1,
 'maxSupply': None,
 'messageBoardId': 'finmb_374263734',
 'morningStarOverallRating': None,
 'morningStarRiskRating': None,
 'mostRecentQuarter': None,
 'navPrice': 22.97,
 'netIncomeToCommon': None,
 'nextFiscalYearEnd': None,
 'open': 24.02,
 'openInterest': None,
 'payoutRatio': None,
 'pegRatio': None,
 'phone': '800-621-1675',
 'previousClose': 24.4,
 'priceHint': 2,
 'priceToBook': None,
 'priceToSalesTrailing12Months': None,
 'profitMargins': None,
 'quoteType': 'ETF',
 'regularMarketDayHigh': 24.41,
 'regularMarketDayLow': 23.4643,
 'regularMarketOpen': 24.02,
 'regularMarketPreviousClose': 24.4,
 'regularMarketPrice': 24.02,
 'regularMarketVolume': 20273,
 'revenueQuarterlyGrowth': None,
 'shortName': 'First Trust Nasdaq Pharmaceutic',
 'startDate': None,
 'strikePrice': None,
 'symbol': 'FTXH',
 'threeYearAverageReturn': 0.0502,
 'toCurrency': None,
 'totalAssets': 12570472,
 'tradeable': False,
 'trailingAnnualDividendRate': None,
 'trailingAnnualDividendYield': None,
 'trailingEps': None,
 'twoHundredDayAverage': 22.18167,
 'volume': 20273,
 'volume24Hr': None,
 'volumeAllCurrencies': None,
 'yield': 0.0086,
 'ytdReturn': None}